News from eli lilly and company

Jul 16, 2014, 08:15 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease

 Eli Lilly and Company (NYSE: LLY) today announced new data showing that beta-amyloid imaging was associated with altered diagnosis and...

Jul 16, 2014, 07:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies

Eli Lilly and Company (NYSE: LLY) and Immunocore Limited today announced they have entered into a co-discovery and co-development collaboration to...

Jul 15, 2014, 02:30 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

New Data Shows Cognitive Impairment Precedes and Predicts Subsequent Functional Impairment in Patients with Mild Alzheimer's Disease

 Today, Eli Lilly and Company (NYSE:LLY) announced results from an analyses of five datasets evaluating the relationship between cognitive and...

Jul 13, 2014, 10:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice

 Eli Lilly and Company (NYSE: LLY) today announced results from its non-clinical study in genetically engineered mice examining combination...

Jul 10, 2014, 13:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly for Better Health™ expands website's non-product-branded health education resources, focuses on healthy behavior skills

 Eli Lilly and Company (NYSE: LLY) has rebooted the Lilly for Better Health™ program, with several innovative enhancements to...

Jul 10, 2014, 13:00 ET
Jul 09, 2014, 12:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly Confirms Date and Conference Call for Second-Quarter 2014 Financial Results Announcement

 Eli Lilly and Company (NYSE: LLY) will announce its financial results for the second quarter of 2014 on Thursday, July 24, 2014.  Lilly...

Jul 08, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly to Showcase Data from its Alzheimer's Disease Portfolio at the Alzheimer's Association International Conference 2014 (AAIC 2014)

 Eli Lilly and Company (NYSE: LLY) today announced that 23 presentations will be given at the Alzheimer's Association International Conference...

Jul 07, 2014, 16:35 ET
Ryan Reed (PRNewsFoto/Eli Lilly and Company)

NASCAR Driver Ryan Reed Finishes Fourth at the Subway Firecracker 250 at Daytona International Speedway

News Highlights: - #DiabetesChamp & Lilly #Diabetes ambassador @driverRyanReed finishes 4th at the Subway Firecracker 250 -...

Jun 27, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

CHMP Recommends Lilly and Boehringer Ingelheim's Investigational New Insulin Glargine Product for Approval in the European Union

 The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational...

Jun 27, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

CHMP Recommends Lilly and Boehringer Ingelheim's New Insulin Glargine Product for Approval in the European Union

The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational compound...

Jun 25, 2014, 09:00 ET
Lilly Diabetes Logo.  (PRNewsFoto/Eli Lilly and Company)

Diabetes Scholars Foundation Announces 2014 Scholarship Recipients

Managing a chronic disease like type 1 diabetes can be difficult for a person of any age, but can be especially daunting while navigating the halls...

Jun 23, 2014, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Eli Lilly and Company Collaborates with Public and Private Healthcare Organizations to Provide Medical Students an Opportunity to Explore Healthcare Outside the Traditional Learning Environment

Students from Marian University College of Osteopathic Medicine are onsite at Eli Lilly and Company (NYSE: LLY) corporate headquarters in...

Jun 17, 2014, 15:53 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Type 2 diabetes: Boehringer Ingelheim and Eli Lilly and Company announce resubmission of New Drug Application for empagliflozin to FDA

 Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced the resubmission of a New Drug...

Jun 16, 2014, 18:15 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly Announces Detailed Results from Two Phase III Studies Testing Both Doses of Dulaglutide vs. Insulin Glargine

Eli Lilly and Company (NYSE: LLY) today released detailed results from two AWARD trials that showed treatment with once-weekly dulaglutide 1.5 mg...

Jun 16, 2014, 14:15 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly Declares Third-Quarter 2014 Dividend

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2014 of $0.49 per share on...

Jun 16, 2014, 11:45 ET
Boehringer Ingelheim logo.  (PRNewsFoto/Eli Lilly and Company)

Type 2 diabetes: Investigational compound empagliflozin as an add-on therapy significantly reduced blood glucose and body weight in two newly presented phase III trials

Two phase III clinical trials studying the efficacy and safety of the investigational compound empagliflozin in type 2 diabetes (T2D) were...

Jun 15, 2014, 15:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Type 2 Diabetes: Investigational Empagliflozin/Linagliptin Combination Tablet Showed Reduction in Blood Glucose in Two Phase III Trials

 Two phase III clinical trials found  the investigational combination tablet of empagliflozin and linagliptin reduced blood glucose levels...

Jun 14, 2014, 13:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Studies Show Investigational New Insulin Glargine Product from Lilly and Boehringer Ingelheim Similar Safety and Efficacy Profile to Lantus®

For the first time today, Eli Lilly and Company (NYSE:LLY) and Boehringer Ingelheim Pharmaceuticals Inc. presented data showing that LY2963016, the...

Jun 14, 2014, 13:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Lilly's Basal Insulin Peglispro Shows Novel Mechanism of Action

Eli Lilly and Company (NYSE: LLY) today announced new data regarding the mechanism of action of basal insulin peglispro (BIL). When BIL and insulin...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge